Fundz

Epalex reported raising $4 Million in an initial SEC Form D filing, from an offering of $15 Million

PRIVATEDec 20, 2024$4M of $15M raised

Amount Raised

$4 Million

$4 Million sold, per SEC Form D (first sale Dec 9, 2024)

Round Type

Seed

Mountain ViewHealthcareHealth Care

Quick answer

Epalex raised $4 Million in a Seed round, dated December 9, 2024. Epalex is based in Mountain View, California, United States.

How much did Epalex raise?
Epalex raised $4 Million in a Seed round on December 9, 2024.
What does Epalex do?
EpaleX is developing a novel inhaled treatment for epilepsy and migraine.
Where is Epalex based and how big is it?
Epalex is based in Mountain View, California, United States.
Who are the decision-makers at Epalex?
Fundz holds 1 contact at Epalex, including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Epalex, and when

A new round usually means Epalex is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Epalex raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Epalex, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Epalex. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Epalex

Location

1049 EL MONTE AVENUE, SUITE C 585

Mountain View, California, United States

About

EpaleX is developing a novel inhaled treatment for epilepsy and migraine. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. When a seizure warning sign (aura) occurs, the patient will be able to prevent the development of a full-blown seizure through the use of a pocket nebulizer to deliver a powerful antiseizure medication that rapidly enters the brain and stops the seizure. The effect of the drug dissipates within minutes, allowing the patient to resume normal daily activity. The inhaler is also used to stop migraine attacks that are refractory to currently available migraine treatments.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Epalex raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsRandall M., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Epalex's next move

See what Strategic adds

Epalex raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.